secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2022-12-09T23:59:59+00:00
Accession:  0001683168-22-008309
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma receives Nasdaq bid price deficiency notice; 180-day cure period until June 5, 2023
--------------------------------------------------------------------------------

- Nasdaq notified SBFM on Dec 6, 2022 that bid price closed below $1.00 for 30 consecutive trading days.
- Company must regain compliance by June 5, 2023 by closing at $1.00+ for 10 consecutive business days.
- If not compliant by June 5, SBFM may qualify for an additional 180-day extension if it meets other listing standards.
- Company says it will monitor bid price and consider options including a reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316822008309/0001683168-22-008309-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316822008309/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-008309

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer